Total Valuation
Encompass Health has a market cap or net worth of €10.70B. The enterprise value is €13.63B.
Market Cap€10.70B
Enterprise Value€13.63B
Share Statistics
Encompass Health has 98,653,380 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding98,653,380
Owned by Insiders1.00%
Owned by Institutions2.98%
Financial Efficiency
Encompass Health’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 13.28%.
Return on Equity (ROE)0.23
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)13.28%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee199.85K
Profits Per Employee19.10K
Employee Count29,699
Asset Turnover0.84
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Encompass Health is 19.6. Encompass Health’s PEG ratio is 0.78.
PE Ratio19.6
PS Ratio1.80
PB Ratio4.37
Price to FCF24.29
Price to Operating Cash Flow9.91
PEG Ratio0.78
Income Statement
In the last 12 months, Encompass Health had revenue of 5.94B and earned 566.20M in profits. Earnings per share was 5.62.
Revenue5.94B
Gross Profit2.56B
Operating Income1.05B
Pretax Income953.00M
Net Income566.20M
EBITDA1.40B
Earnings Per Share (EPS)5.62
Cash Flow
In the last 12 months, operating cash flow was 1.21B and capital expenditures -799.10M, giving a free cash flow of 413.40M billion.
Operating Cash Flow1.21B
Free Cash Flow413.40M
Free Cash Flow per Share4.19
Dividends & Yields
Encompass Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.34
52-Week Price Change1.68%
50-Day Moving Average107.34
200-Day Moving Average93.95
Relative Strength Index (RSI)59.11
Average Volume (3m)0.00
Important Dates
Encompass Health upcoming earnings date is Oct 28, 2026, After Close (Confirmed).
Last Earnings DateAug 5, 2026
Next Earnings DateOct 28, 2026
Ex-Dividend Date―
Financial Position
Encompass Health as a current ratio of 1.08, with Debt / Equity ratio of 109.42%
Current Ratio1.08
Quick Ratio1.08
Debt to Market Cap0.21
Net Debt to EBITDA1.86
Interest Coverage Ratio8.55
Taxes
In the past 12 months, Encompass Health has paid 192.90M in taxes.
Income Tax192.90M
Effective Tax Rate0.20
Enterprise Valuation
Encompass Health EV to EBITDA ratio is 9.46, with an EV/FCF ratio of 30.23.
EV to Sales2.24
EV to EBITDA9.46
EV to Free Cash Flow30.23
EV to Operating Cash Flow11.29
Balance Sheet
Encompass Health has €107.70M in cash and marketable securities with €2.84B in debt, giving a net cash position of -€2.73B billion.
Cash & Marketable Securities€107.70M
Total Debt€2.84B
Net Cash-€2.73B
Net Cash Per Share-€27.72
Tangible Book Value Per Share€16.42
Margins
Gross margin is 43.86%, with operating margin of 17.74%, and net profit margin of 9.54%.
Gross Margin43.86%
Operating Margin17.74%
Pretax Margin16.06%
Net Profit Margin9.54%
EBITDA Margin23.66%
EBIT Margin18.13%
Analyst Forecast
The average price target for Encompass Health is €130.84, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€130.84
Price Target Upside27.03% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast2.02%
EPS Growth Forecast11.62%